Endoscopic resection for gastric submucosal tumors: A single-center experience in Japan
- PMID: 39011512
- PMCID: PMC11249007
- DOI: 10.1002/deo2.402
Endoscopic resection for gastric submucosal tumors: A single-center experience in Japan
Abstract
Objectives: Endoscopic resection (ER) for gastric submucosal tumors (SMTs) has gained prominence in recent years, with studies emerging from various countries. However, there is a paucity of reports from Japan. We aimed to elucidate the efficacy and safety of ER for gastric SMT in Japan.
Methods: In this retrospective observational study, we investigated the outcomes of consecutive patients who underwent ER for gastric SMT from January 2017 to May 2023. The outcome variables assessed included the complete resection rate, procedure time, closure-related outcomes, and the incidence of adverse events.
Results: A total of 13 patients were included in the analysis. The median procedure time was 163 (55-283) min. Complete full-thickness resection was performed in seven cases, while in four cases, the serosa remained, and in two cases, the outer layer of the muscularis propria remained. In two cases where the SMT was located on the anterior side, conversion to laparoscopic surgery became necessary, resulting in a procedural success rate of 84.6% (11/13). Excluding these two cases, endoscopic closure of the defect was successfully accomplished in the remaining 11 cases. R0 resection was achieved in 12 out of 13 cases (92.3%). Although one patient had peritonitis, which was successfully treated conservatively, no other treatment-related adverse events were encountered.
Conclusions: Although ER for SMT on the anterior side may be challenging, our experience revealed that ER is a safe and efficacious approach for gastric SMT.
Keywords: endoscopic full‐thickness resection; endoscopic muscularis dissection; endoscopic resection; endoscopic subserosal dissection; gastric submucosal tumors.
© 2024 The Author(s). DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.
Conflict of interest statement
Author Haruhiro Inoue is an advisor for Olympus Corporation and Top Corporation. He has also received educational grants from Olympus Corporation and Takeda Pharmaceutical Co. The other authors declare no conflict of interest.
Figures



References
-
- Japan Society of Clinical Oncology . Clinical practice guideline for gastrointestinal stromal tumor [Internet], Tokyo: Japan Society of Clinical Oncology; 2014. Available from: http://jsco-cpg.jp/item/03/index.html. Japanese.
-
- Yip HC, Teh JL, Teoh AY, Chiu PWY. Pure endoscopic resection versus laparoscopic assisted procedure for upper gastrointestinal stromal tumors: Perspective from a surgical endoscopist. Dig Endosc 2023; 35: 184–194. - PubMed
-
- Hiki N, Yamamoto Y, Fukunaga T et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc 2008; 22: 1729–1735. - PubMed
-
- Matsuda T, Hiki N, Nunobe S et al. Feasibility of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors (with video). Gastrointest Endosc 2016; 84: 47–52. - PubMed
-
- Ojima T, Nakamura M, Nakamori M et al. Laparoscopic and endoscopic cooperative surgery is a feasible treatment procedure for intraluminal gastric gastrointestinal stromal tumors compared to endoscopic intragastric surgery. Surg Endosc 2018; 32: 351–357. - PubMed
LinkOut - more resources
Full Text Sources